4519:TYO
Chugai Pharmaceutical Co Ltd
JPÂ¥6Â 052,00
arrow_downward
-0,80%(-49,00) 1D
8 Okt., 11:30:00 GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4519...
Open
JPÂ¥6Â 181
High
JPÂ¥6Â 188
Low
JPÂ¥6Â 046
Mkt. cap
10,11Â bn
Avg. vol.
2,89Â m
Volume
677,80Â k
Dividend
2,28%
Quarterly dividend
JPÂ¥35
Ex-dividend date
29 Jun. 2026
P/E ratio
21,13
52-wk high
JPÂ¥10Â 700
52-wk low
JPÂ¥5Â 974
EPS
JPÂ¥286
Shares outstanding
547,19Â m
No. of employees
5Â k
Open
JPÂ¥6Â 181
High
JPÂ¥6Â 188
Low
JPÂ¥6Â 046
Mkt. cap
10,11Â bn
Avg. vol.
2,89Â m
Volume
677,80Â k
Dividend
2,28%
Quarterly dividend
JPÂ¥35
Ex-dividend date
29 Jun. 2026
P/E ratio
21,13
52-wk high
JPÂ¥10Â 700
52-wk low
JPÂ¥5Â 974
EPS
JPÂ¥286
Shares outstanding
547,19Â m
No. of employees
5Â k
News stories
From web sources and news partners
AD HOC NEWS
·
19 uur gelede
Chugai Pharmaceutical stock heads toward October 27 results after pipeline shift
Simply Wall Street
·
1 dag gelede
Chugai Pharmaceutical (TSE:4519) Is Back In Focus, What Is Behind The Attention?
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5,1Â k
Founded10 Mrt. 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp